← Leaderboards
Larry Charles Lasky
Ohio State University
$764,226
Attributed
$764,226
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$764,226 · 1
By mechanism
R21$764,226 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Rama K Mallampalli$45,256,042
- David P Carbone$20,647,321
- Sumithira Vasu$6,137,636
- John F Sheridan$19,868,269
- Ginny L Bumgardner$11,783,970
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisBiotechnologyBone MarrowCell DifferentiationCell Growth RegulationCell Population StudyClinical ResearchCord BloodGene Environment InteractionGene ExpressionGenetic ManipulationGenetic MarkersGrowth FactorHematopoietic Stem CellsHematopoietic Tissue TransplantationHormone InhibitorHuman SubjectImmunosuppressiveIn Situ HybridizationLaboratory MouseMifepristonePatient Oriented ResearchSirolimusTransfection /Expression Vector
Grant awards (4)
Engineered Hematopoietic Cell Self-renewal and Death$214,476
R21 · FY2006 · HL · contact PI
Engineered Hematopoietic Cell Self-renewal and Death$183,250
R21 · FY2004 · HL
Engineered Hematopoietic Cell Self-renewal and Death$183,250
R21 · FY2003 · HL
Engineered Hematopoietic Cell Self-renewal and Death$183,250
R21 · FY2002 · HL